Intrauterine Devices Market Growth Outlook Through 2024-2033

Overview and Scope
Intrauterine devices refer to small, T-shaped contraceptive devices that are inserted into the uterus to prevent pregnancy. These devices provide a highly effective and long-lasting method of birth control. It works by altering the uterine environment to make it less conducive for sperm to fertilize an egg and, in some cases, affecting the uterine lining to inhibit implantation.

Sizing and Forecast
The intrauterine devices market size has grown strongly in recent years. It will grow from $3.75 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to family planning initiatives, women’s empowerment, long-acting reversible contraception (larc), high contraceptive efficacy, cost-effectiveness, reduced side effects, healthcare professional advocacy..

The intrauterine devices market size is expected to see steady growth in the next few years. It will grow to $4.74 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing awareness and education, global health initiatives, shift towards non-hormonal options, expanding access to healthcare, personalized contraceptive choices, youth-friendly reproductive services, integration with primary care services.. Major trends in the forecast period include development of frameless iuds, innovation in biodegradable iuds, enhancements in user-friendly insertion systems, integration of contraceptive counseling services, exploration of non-contraceptive health benefits..

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/intrauterine-devices-global-market-report

Segmentation & Regional Insights
The intrauterine devices market covered in this report is segmented –

1) By Product: Hormonal Intrauterine Device, Copper Intrauterine Device
2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years
3) By End-User: Hospitals, Gynaecology Clinics, Community Healthcare, Other End Users

North America was the largest region in the intrauterine devices market in 2023. The regions covered in the intrauterine devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13464&type=smp

Major Driver Impacting Market Growth
The increasing number of unplanned pregnancies is expected to propel the growth of the intrauterine devices market going forward. Unplanned pregnancies are defined as pregnancies that are either unwanted or unplanned, such as those that happen when no children or additional children are desired. Intrauterine devices (IUDs) are a very efficient method of birth control that prevents pregnancy by modifying the uterine environment to make it less suitable for sperm to fertilize an egg. For instance, in March 2022, according to the United Nations Population Fund, a US-based sexual and reproductive health agency, there are 121 million unintended pregnancies globally each year. Moreover, Afghanistan’s unintended pregnancies are expected to reach 4.8 million in 2025. Therefore, the increasing number of women in the workforce is driving the growth of the intrauterine devices market.

Key Industry Players
Major companies operating in the intrauterine devices market report are Cardinal Health Inc., Pfizer Inc., Merck and Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Perrigo Company plc., CooperSurgical Inc., BIOTRONIK Inc., HLL Lifecare Limited, ANI Pharmaceuticals, Actavis GmbH, DKT International Inc., Nipro Medical Corporation, Pfm medical Inc., Besins HealthCare Limited, Pregna International Limited, SCITECH Medical Inc., Viatris Inc., Medicines360, Afaxys Inc., Access Vascular Inc., OCON Medical Ltd., Agile Therapeutics Inc., SMB Corporation of India, Eurogine S.L.</b

The intrauterine devices market report table of contents includes:

1. Executive Summary
2. Intrauterine Devices Market Characteristics
3. Intrauterine Devices Market Trends And Strategies
4. Intrauterine Devices Market – Macro Economic Scenario
5. Global Intrauterine Devices Market Size and Growth
.
.
.
32. Global Intrauterine Devices Market Competitive Benchmarking
33. Global Intrauterine Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Intrauterine Devices Market
35. Intrauterine Devices Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On: 
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model